Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% between 2024 and 2025.
Oncology medication revenue is projected to grow 7.6%, reaching $208.86 billion in 2025. Other lucrative pharmaceutical markets in 2025 include:
- Anti-diabetes drugs — $84.48 billion (8.3% growth from 2024)
- Vaccines — $69.21 billion (-6.6%)
- Immunosuppressants — $61.05 billion (15.1%)
- Antiviral drugs — $52.19 billion (2%)
- Anti-rheumatic drugs — $47.33 billion (-0.7%)
By 2026, Statista predicted the cell therapy market will reach $87.22 billion, gene therapies will reach $13.25 billion and nucleic acid therapies will hit $1.35 billion.
Oncology is expected to account for the largest chunk of the next generation of therapeutic areas, with a projected $62.54 billion market value. The other leading therapeutic areas are expected to be multiple sclerosis ($12.66 billion) and inflammatory rheumatism ($5.77 billion).